HEALTH
- Share via
From Times Staff and Wire Reports
Mylan Turns Aside Speculation About Takeover: The weekend death of Mylan Laboratories Inc.’s chairman and chief executive heated up rumors that the manufacturer of generic drugs could be a takeover candidate. Roy McKnight died of a heart attack while vacationing in Florida, said David Saks, an analyst with Gruntal & Co. Company officials downplayed the talk, but in heavy trading on the New York Stock Exchange, Mylan jumped $2.50 a share to close at $32.625 in heavy trading.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
